Annual Influenza Vaccine Effectiveness Estimates in Healthy and High-risk Populations

The summary for the Annual Influenza Vaccine Effectiveness Estimates in Healthy and High-risk Populations grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Annual Influenza Vaccine Effectiveness Estimates in Healthy and High-risk Populations: CDC?s Procurement and Grants Office has published a program announcement entitled, ?Annual Influenza Vaccine Effectiveness Estimates in Healthy and High-risk Populations?. Approximately $500,000 will be available in fiscal year 2004 to fund one to two awards. Influenza vaccination is the best way to prevent influenza and its severe complications. Each year the Advisory Committee for Immunization Practices (ACIP) reviews the annual recommendations for influenza vaccination and uses new studies or other evidence gained over the previous years to decide if there should be new target groups for immunization. The purpose of the program is to support epidemiologic studies, (e.g. cohort or case control) designed to provide annual vaccine effectiveness, with laboratory confirmation of influenza illness, estimates at regular intervals throughout the influenza season, with a final estimate at the end of the season. These data will provide better estimates of the benefits of influenza vaccine and will be valuable in guiding vaccine policy development. These studies should be designed to provide estimates of the effectiveness of influenza vaccine in reducing laboratory confirmed illness among vaccinated persons, both among pediatric and adult age groups, on an annual basis, during the influenza season and at the end of the influenza season. The application deadline is June 10, 2004, and the estimated funding date is August 16, 2004.